MediVie   Report issue

For profit Phase 3
Founded: Hemel Hempstead United Kingdom (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2012
NCT01068912
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now